NUVASIVE $22.81

up +0.47


19/6/2013 12:19 PM  |  NASDAQ : NUVA  |  Industries : Manufacturing / Medical Equipment and Supplies Manufacturing
Get Trend Analysis Icon Get NUVA Trend Analysis - it has underperformed the S&P 500 by 23%

Partner Headlines

  1. Mid-Afternoon Market Update: NuVasive Rises While EXCO Resourced Drops

    Benzinga
  2. Mid-Day Market Update: Markets Remain Up, Dynavax Continues Rally

    Benzinga
  3. Benzinga's Top Upgrades

    Benzinga
  4. NuVasive Announces First Patient in the United States Treated With ...

    Benzinga
  5. NuVasive(R) Announces Release of $62.5M From Escrow Following ...

    Benzinga
  6. NuVasive to Release $62.5M from Escrow Following Appeals Court Win

    Benzinga
  7. Covidien Stock Rises After Earnings Beat Estimates

    Investors Business Daily
  8. NuVasive Announces PMA Approval of the PCM(R) Cervical Disc System

    Benzinga
  9. NuVasive Inc. Reports Operating Results (10-Q)

    GuruFocus
  10. Benzinga's Top Downgrades

    Benzinga
  11. UPDATE: Goldman Sachs Reduces PT to $16 on NuVasive on Sales Outlook

    Benzinga
  12. Intuitive Surgical Stock Rebounds From Q3 Dive

    Investors Business Daily
  13. Intuitive Surgical Stock Upgraded Ahead Of Q3 Report

    Investors Business Daily
  14. FDA Ruling on Artificial Disc Boosts Globus Medical

    Investors Business Daily
  15. The Hell With NuVasive Stock: Get Hired by One of its Competitors ...

    YCharts
  16. Stocks Post Gains after Positive Data with Bank of America (BAC) ...

    At Market Intelligence Center
  17. Nuvasive (NUVA) Drops 33% on Weak Q3 Revenue

    At Market Intelligence Center
  18. Benzinga Mid-Afternoon Market Update

    Benzinga
  19. Stock Futures Point to Higher Open Ahead of Data with Facebook ...

    At Market Intelligence Center
  20. UPDATE: BMO Capital Markets Downgrades NuVasive to Underperform on ...

    Benzinga
  21. Benzinga Mid-Morning Market Update

    Benzinga
  22. US Stock Futures Up; Jobless Claims, ECB Meeting In Focus

    Benzinga
  23. Stocks To Watch For October 4, 2012

    Benzinga
  24. Nuvasive

    Investors Business Daily
  25. NuVasive Cuts Q3 Prelim Revenue, Forecast $147M

    Benzinga
  26. NuVasive Inc. Reports Operating Results (10-Q)

    GuruFocus
  27. Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying

    Benzinga
  28. Analyst Upgrades: NUVA, ONXX, and SKUL

    By SchaeffersResearch
  29. Analyst Upgrades: NUVA, QCOM, and SPWR

    By SchaeffersResearch
  30. NuVasive Up 20% After Q1 Earnings

    Benzinga
  31. NuVasive Inc. Reports Operating Results (10-K)

    at GuruFocus
  32. Top 4 Small-Cap Stocks In The Healthcare Sector With The Highest Cash

    at Benzinga
  33. UPDATE: BMO Capital Markets Increases Target to $16 on Nuvasive

    at Benzinga
  34. UPDATE: Canaccord Genuity Upgrades NuVasive to Buy, Maintains $19 PT

    at Benzinga
  35. Canaccord Upgrades NuVasive to Buy

    at Benzinga
  36. Notable Call Options Activity in NuVasive

    at Benzinga
  37. NUVA hit with downgrade and two price-target cuts

    By SchaeffersResearch
People viewing NUVA also viewed: , , , , , ,
Marketplace
Trading Center